Compare AVA & MMSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | AVA | MMSI |
|---|---|---|
| Founded | 1889 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 1994 | 1996 |
| Metric | AVA | MMSI |
|---|---|---|
| Price | $41.00 | $66.51 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $39.00 | ★ $98.88 |
| AVG Volume (30 Days) | 421.4K | ★ 500.2K |
| Earning Date | 05-05-2026 | 04-30-2026 |
| Dividend Yield | ★ 4.78% | N/A |
| EPS Growth | 3.93 | ★ 4.93 |
| EPS | ★ 2.38 | 2.13 |
| Revenue | ★ $1,964,000,000.00 | $1,515,906,000.00 |
| Revenue This Year | $3.11 | $8.85 |
| Revenue Next Year | $4.44 | $5.88 |
| P/E Ratio | ★ $17.26 | $31.68 |
| Revenue Growth | 1.34 | ★ 11.75 |
| 52 Week Low | $35.50 | $66.34 |
| 52 Week High | $43.50 | $99.26 |
| Indicator | AVA | MMSI |
|---|---|---|
| Relative Strength Index (RSI) | 51.42 | 38.10 |
| Support Level | $40.85 | N/A |
| Resistance Level | $42.02 | $71.68 |
| Average True Range (ATR) | 0.76 | 1.83 |
| MACD | -0.07 | -0.04 |
| Stochastic Oscillator | 45.53 | 12.35 |
Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P segment is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.
Merit Medical Systems Inc is a medical equipment company that develops and manufactures products for interventional cardiology, radiology, and endoscopy procedures. The firm reports two segments which are Cardiovascular and Endoscopy. The majority of the revenue is earned from the Cardiovascular segment which consists of cardiology and radiology medical device products that assist in diagnosing and treating coronary artery disease, peripheral vascular disease, and other non-vascular diseases and includes embolotherapeutic, cardiac rhythm management, electrophysiology, critical care, and interventional oncology and spine devices.